Checchi Capital Advisers’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.02M Sell
19,940
-446
-2% -$96K 0.23% 79
2026
Q1
$4.43M Buy
20,386
+645
+3% +$143K 0.22% 76
2025
Q4
$4.51M Sell
19,741
-130
-0.7% -$29.6K 0.23% 74
2025
Q3
$4.6M Sell
19,871
-1,484
-7% -$302K 0.24% 75
2025
Q2
$3.96M Sell
21,355
-2,492
-10% -$463K 0.22% 86
2025
Q1
$5M Buy
23,847
+494
+2% +$96K 0.26% 70
2024
Q4
$4.15M Buy
23,353
+61
+0.3% +$11.2K 0.24% 80
2024
Q3
$4.6M Buy
23,292
+677
+3% +$126K 0.26% 70
2024
Q2
$3.88M Sell
22,615
-36
-0.2% -$5.96K 0.19% 72
2024
Q1
$4.12M Buy
22,651
+135
+0.6% +$23.3K 0.32% 74
2023
Q4
$3.49M Sell
22,516
-703
-3% -$102K 0.28% 76
2023
Q3
$3.46M Buy
23,219
+294
+1% +$43.2K 0.32% 72
2023
Q2
$3.09M Sell
22,925
-558
-2% -$81.8K 0.28% 80
2023
Q1
$3.74M Buy
23,483
+531
+2% +$81.2K 0.36% 63
2022
Q4
$3.71M Sell
22,952
-1,435
-6% -$220K 0.39% 64
2022
Q3
$3.27M Buy
24,387
+282
+1% +$40.5K 0.31% 75
2022
Q2
$3.46M Buy
24,105
+3,005
+14% +$459K 0.3% 72
2022
Q1
$3.42M Buy
21,100
+2,425
+13% +$352K 0.29% 64
2021
Q4
$2.53M Buy
18,675
+247
+1% +$29.2K 0.22% 74
2021
Q3
$1.99M Sell
18,428
-446
-2% -$51K 0.2% 89
2021
Q2
$2.13M Sell
18,874
-230
-1% -$25.9K 0.21% 89
2021
Q1
$2.07M Sell
19,104
-659
-3% -$70.5K 0.2% 89
2020
Q4
$2.12M Sell
19,763
-2,579
-12% -$248K 0.22% 84
2020
Q3
$1.96M Sell
22,342
-2,215
-9% -$209K 0.22% 75
2020
Q2
$2.41M Buy
24,557
+2,814
+13% +$248K 0.29% 53
2020
Q1
$1.66M Buy
21,743
+1,033
+5% +$88K 0.16% 69
2019
Q4
$1.83M Buy
20,710
+3,484
+20% +$289K 0.25% 70
2019
Q3
$1.3M Hold
17,226
0.17% 81
2019
Q2
$1.25M Buy
17,226
+1,606
+10% +$126K 0.16% 85
2019
Q1
$1.26M Sell
15,620
-1,261
-7% -$103K 0.15% 84
2018
Q4
$1.56M Sell
16,881
-2,557
-13% -$225K 0.2% 69
2018
Q3
$1.84M Buy
19,438
+276
+1% +$26.2K 0.21% 67
2018
Q2
$1.77M Buy
19,162
+402
+2% +$39.3K 0.22% 64
2018
Q1
$1.78M Buy
18,760
+222
+1% +$24.4K 0.23% 65
2017
Q4
$1.79M Buy
18,538
+2,828
+18% +$267K 0.24% 69
2017
Q3
$1.4M Sell
15,710
-509
-3% -$38.7K 0.14% 74
2017
Q2
$1.18M Sell
16,219
-2,336
-13% -$157K 0.13% 81
2017
Q1
$1.21M Buy
18,555
+1,924
+12% +$121K 0.14% 80
2016
Q4
$1.04M Buy
16,631
+872
+6% +$53.2K 0.14% 80
2016
Q3
$994K Buy
15,759
+1,102
+8% +$71.3K 0.11% 85
2016
Q2
$907K Buy
14,657
+722
+5% +$44K 0.1% 86
2016
Q1
$796K Sell
13,935
-2,092
-13% -$117K 0.18% 92
2015
Q4
$949K Buy
16,027
+1,324
+9% +$76.3K 0.24% 87
2015
Q3
$800K Buy
14,703
+832
+6% +$54.2K 0.22% 88
2015
Q2
$932K Sell
13,871
-52
-0.4% -$3.4K 0.25% 77
2015
Q1
$815K Buy
13,923
+2,062
+17% +$125K 0.24% 87
2014
Q4
$776K Buy
11,861
+936
+9% +$59K 0.29% 77
2014
Q3
$631K Buy
10,925
+3,436
+46% +$191K 0.26% 84
2014
Q2
$423K Buy
7,489
+1,040
+16% +$54.6K 0.19% 98
2014
Q1
$331K Buy
6,449
+1,253
+24% +$63.3K 0.2% 102
2013
Q4
$274K Buy
+5,196
New +$255K 0.21% 98

Other funds holding ABBV

Checchi Capital Advisers's ABBV Position: Q2 2026 in Review

Checchi Capital Advisers reduced its AbbVie (ABBV) stake by 2.2% in Q2 2026, selling an estimated $96K and leaving 19,940 shares worth $5.02M. The position accounts for 0.23% of the portfolio, ranked #79.

Checchi Capital Advisers first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. 3,018 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Checchi Capital Advisers held 19,940 shares of AbbVie worth $5.02M as of Q2 2026.
  • Checchi Capital Advisers sold 446 AbbVie shares in Q2 2026, an estimated $96K.
  • AbbVie made up 0.23% of Checchi Capital Advisers's portfolio in Q2 2026, its #79 holding.
  • Checchi Capital Advisers first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
  • 3,018 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.